We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+23.86%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.03B
AUM Growth
+$185M
Cap. Flow
+$7.71M
Cap. Flow %
0.75%
Top 10 Hldgs %
33.91%
Holding
181
New
18
Increased
67
Reduced
73
Closed
5

Top Buys

Rank Stock Value
1
USB icon
US Bancorp
USB
+$2.32M
2
RTX icon
RTX Corp
RTX
+$1.89M
3
CB icon
Chubb
CB
+$1.78M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.35M
5
WY icon
Weyerhaeuser
WY
+$1.09M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.81M
2
EBAY icon
eBay
EBAY
+$1.76M
3
DOX icon
Amdocs
DOX
+$1.38M
4
PYPL icon
PayPal
PYPL
+$1.12M
5
AMGN icon
Amgen
AMGN
+$977K

Sector Composition

Rank Sector Weight
1 Technology 28.62%
2 Healthcare 17.49%
3 Financials 12.33%
4 Consumer Staples 9.99%
5 Industrials 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
76
TJX Companies
TJX
$178B
$1.53M 0.15%
30,181
+113
+0.4% +$5.67K
ABT icon
77
Abbott
ABT
$187B
$1.52M 0.15%
16,676
-80
-0.5% -$7.23K
COST icon
78
Costco
COST
$429B
$1.52M 0.15%
5,018
+11
+0.2% +$3.35K
GOOGL icon
79
Alphabet (Google) Class A
GOOGL
$4.08T
$1.42M 0.14%
20,040
+100
+0.5% +$6.74K
NBIX icon
80
Neurocrine Biosciences
NBIX
$18.4B
$1.35M 0.13%
11,036
+600
+6% +$66.3K
BMRN icon
81
BioMarin Pharmaceuticals
BMRN
$12B
$1.31M 0.13%
10,633
+695
+7% +$69.1K
HD icon
82
Home Depot
HD
$343B
$1.31M 0.13%
5,248
+50
+1% +$11.4K
GOOG icon
83
Alphabet (Google) Class C
GOOG
$4.07T
$1.29M 0.12%
18,240
+560
+3% +$37.8K
FAST icon
84
Fastenal
FAST
$55.2B
$1.28M 0.12%
59,712
+572
+1% +$10.9K
INCY icon
85
Incyte
INCY
$26B
$1.24M 0.12%
11,953
+760
+7% +$73.3K
HON icon
86
Honeywell
HON
$78.3B
$1.23M 0.12%
8,992
-42
-0.5% -$5.56K
AMZN icon
87
Amazon
AMZN
$2.48T
$1.2M 0.12%
8,720
+480
+6% +$58K
KMB icon
88
Kimberly-Clark
KMB
$37.5B
$1.13M 0.11%
7,979
-120
-1% -$16.6K
IONS icon
89
Ionis Pharmaceuticals
IONS
$9.14B
$1.1M 0.11%
18,701
+1,365
+8% +$75.9K
BMY icon
90
Bristol-Myers Squibb
BMY
$130B
$1.08M 0.1%
18,421
+177
+1% +$10.6K
SPY icon
91
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$1.05M 0.1%
3,390
+2,558
+307% +$749K
ADP icon
92
Automatic Data Processing
ADP
$106B
$1M 0.1%
6,686
-108
-2% -$15.5K
NTR icon
93
Nutrien
NTR
$33.3B
$1M 0.1%
31,098
+138
+0.4% +$4.8K
VV icon
94
Vanguard Large-Cap ETF
VV
$52B
$990K 0.1%
6,895
+2,215
+47% +$299K
V icon
95
Visa
V
$697B
$930K 0.09%
4,828
+30
+0.6% +$5.48K
UNP icon
96
Union Pacific
UNP
$175B
$920K 0.09%
5,457
+95
+2% +$15.2K
VEU icon
97
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$900K 0.09%
18,960
+3,360
+22% +$151K
ISRG icon
98
Intuitive Surgical
ISRG
$130B
$880K 0.09%
4,638
EMR icon
99
Emerson Electric
EMR
$85B
$870K 0.08%
14,058
-265
-2% -$15.1K
CTRA
100
DELISTED
Coterra Energy
CTRA
$860K 0.08%
50,121
-55
-0.1% -$1.07K

Similar funds

Grandfield & Dodd's Q2 2020 Portfolio in Review

As of Q2 2020, Grandfield & Dodd held 181 positions worth $1.03B, up 22% from $848M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Grandfield & Dodd's Q2 2020 filing shows 18 new, 67 increased, 73 reduced and 5 closed positions. Its largest new stake was Hexcel: 14,335 shares worth $650K. The largest sale was Microsoft, an estimated $1.81M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q2 2020 buy was Hexcel: 14,335 shares worth $650K.
  • Grandfield & Dodd added most to US Bancorp in Q2 2020, an estimated $2.32M increase.
  • Grandfield & Dodd's biggest Q2 2020 reduction was Microsoft, cutting an estimated $1.81M.
  • Grandfield & Dodd fully exited SPDR Gold Trust in Q2 2020, selling an estimated $848K.
  • Grandfield & Dodd's ten largest holdings make up 34% of its $1.03B portfolio in Q2 2020.
  • Grandfield & Dodd opened 18 new positions and closed 5 in Q2 2020.
  • Grandfield & Dodd's portfolio value rose 22% quarter-over-quarter to $1.03B.

Based on Grandfield & Dodd's 13F filing for Q2 2020, filed 24 Jul 2020.